E-LIB Suche - Ergebnisse für: Home, Philip

1

Insulin biobetters and biosimilars in clinical practice:

Home, Philip
Journal of the Royal College of Physicians of Edinburgh. 53 (2023) 2 - p. 147-155 , 2023

2

Findings for iGlarLixi versus BIAsp 30 confirmed in groups ..:

Home, Philip D. ; McCrimmon, Rory J. ; Rosenstock, Julio...
Diabetes, Obesity and Metabolism. 25 (2022) 3 - p. 656-663 , 2022

Link: https://doi.org/10.1111/..

3

Understanding Biosimilar Insulins - Development, Manufactur..:

Heinemann, Lutz ; Davies, Melanie ; Home, Philip...
Journal of Diabetes Science and Technology. 17 (2022) 6 - p. 1649-1661 , 2022

Link: https://doi.org/10.1177/..

4

Hypoglycaemia events with iGlarLixi versus premix biphasic ..:

McCrimmon, Rory J. ; Home, Philip ; Cheng, Alice...
Diabetes, Obesity and Metabolism. 24 (2022) 12 - p. 2391-2399 , 2022

Link: https://doi.org/10.1111/..

5

The path for medical associations to sponsor trustworthy gu..:

Pagano, Domenico ; Home, Philip ; Irs, Alar...
Journal of the Royal Society of Medicine. 115 (2022) 7 - p. 252-256 , 2022

Link: https://doi.org/10.1177/..

6

Efficacy and safety of iGlarLixi versus IDegAsp: Results of..:

Home, Philip D. ; Mehta, Roopa ; Hafidh, Khadija A. S....
Diabetes, Obesity and Metabolism. 23 (2021) 12 - p. 2660-2669 , 2021

Link: https://doi.org/10.1111/..

7

Heart failure management; a perspective from diabetes care:

Itzhak, Baruch ; Home, Philip
Diabetes Research and Clinical Practice. 176 (2021) - p. 108849 , 2021

Link: https://doi.org/10.1016/..

8

The evolution of insulin therapy:

Home, Philip
Diabetes Research and Clinical Practice. 175 (2021) - p. 108816 , 2021

Link: https://doi.org/10.1016/..

9

Future directions in insulin therapy:

Home, Philip
Metabolism. 124 (2021) - p. 154889 , 2021

Link: https://doi.org/10.1016/..

10

Letter to the Editor in Response to article: "Clinical cons..:

Home, Philip
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 14 (2020) 4 - p. 417 , 2020

Link: https://doi.org/10.1016/..

11

Insulin glargine/lixisenatide fixed‐ratio combination (iGla..:

Home, Philip ; Blonde, Lawrence ; Kalra, Sanjay...
Diabetes, Obesity and Metabolism. 22 (2020) 11 - p. 2179-2188 , 2020

Link: https://doi.org/10.1111/..

12

Hypoglycaemia risk with insulin glargine 300 U/mL compared ..:

Bolli, Geremia B. ; Landgraf, Wolfgang ; Bosnyak, Zsolt..
Diabetes, Obesity and Metabolism. 22 (2020) 9 - p. 1664-1669 , 2020

Link: https://doi.org/10.1111/..

13

Efficacy and safety of iGlarLixi versus IDegLira in adults ..:

Home, Philip D. ; Aroda, Vanita R. ; Blonde, Lawrence...
Diabetes, Obesity and Metabolism. 22 (2020) 11 - p. 2170-2178 , 2020

Link: https://doi.org/10.1111/..

14

Tackling obesity during the COVID‐19 pandemic:

Akirov, Amit ; Cahn, Avivit ; Del Prato, Stefano...
Diabetes/Metabolism Research and Reviews. 37 (2020) 3 - p. , 2020

Link: https://doi.org/10.1002/..

15

Commencing insulin glargine 100 U/mL therapy in individuals..:

Owens, David R. ; Landgraf, Wolfgang ; Frier, Brian M....
Diabetes, Obesity and Metabolism. 21 (2019) 2 - p. 321-329 , 2019

Link: https://doi.org/10.1111/..